CAR-T cell therapy is already a potent treatment for certain cancers. Now, a small study is showing early promise for managing HIV.
Emily Mullin is a staff writer at WIRED, covering biotechnology and various aspects of healthcare technology. Her work delves into themes such as digital health, telehealth, and pharmaceutical regulation, reflecting her extensive background in biomedicine and healthcare. Emily's writing has been featured in notable outlets including Teen Vogue, Ars Technica, and National Geographic.












